- Home
- TSHA vs GBX Comparison
TSHA vs GBX Comparison
Compare TSHA & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- GBX
- Stock Information
- Founded
- TSHA 2019
- GBX 1974
- Country
- TSHA United States
- GBX United States
- Employees
- TSHA N/A
- GBX N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- GBX Railroads
- Sector
- TSHA Health Care
- GBX Industrials
- Exchange
- TSHA Nasdaq
- GBX Nasdaq
- Market Cap
- TSHA 1.4B
- GBX 1.5B
- IPO Year
- TSHA 2020
- GBX N/A
- Fundamental
- Price
- TSHA $4.72
- GBX $45.24
- Analyst Decision
- TSHA Strong Buy
- GBX Hold
- Analyst Count
- TSHA 8
- GBX 2
- Target Price
- TSHA $9.63
- GBX $59.50
- AVG Volume (30 Days)
- TSHA 11.3M
- GBX 263.4K
- Earning Date
- TSHA 11-12-2025
- GBX 10-28-2025
- Dividend Yield
- TSHA N/A
- GBX 2.83%
- EPS Growth
- TSHA N/A
- GBX 88.14
- EPS
- TSHA N/A
- GBX 7.10
- Revenue
- TSHA $8,098,000.00
- GBX $3,533,700,000.00
- Revenue This Year
- TSHA N/A
- GBX N/A
- Revenue Next Year
- TSHA N/A
- GBX N/A
- P/E Ratio
- TSHA N/A
- GBX $6.38
- Revenue Growth
- TSHA N/A
- GBX 0.70
- 52 Week Low
- TSHA $1.05
- GBX $37.77
- 52 Week High
- TSHA $5.51
- GBX $71.06
- Technical
- Relative Strength Index (RSI)
- TSHA 59.56
- GBX 46.53
- Support Level
- TSHA $4.80
- GBX $43.90
- Resistance Level
- TSHA $5.51
- GBX $46.55
- Average True Range (ATR)
- TSHA 0.44
- GBX 1.07
- MACD
- TSHA 0.04
- GBX 0.02
- Stochastic Oscillator
- TSHA 66.02
- GBX 41.74
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About GBX Greenbrier Companies Inc. (The)
Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of its revenue from the United States.